Laccase mediated diclofenac transformation and cytotoxicity assessment on mouse fibroblast 3T3-L1 preadipocytes by Sathishkumar, Palanivel et al.
RSC Advances
PAPER
Pu
bl
ish
ed
 o
n 
09
 Ja
nu
ar
y 
20
14
. D
ow
nl
oa
de
d 
on
 7
/2
4/
20
18
 1
:4
6:
32
 A
M
. 
View Article Online
View Journal  | View IssueaInstitute of Environmental and Water Res
Malaysia, 81310 Skudai, Johor
salemsathishkumar@gmail.com; hadibarata
75531760
bDepartment of Microbiology, Dr G. R. Damo
Tamil Nadu, India
cDepartment of Molecular Medicine, Faculty
Kuala Lumpur, Malaysia
dDepartment of Biochemistry, Periyar Unive
Cite this: RSC Adv., 2014, 4, 11689
Received 22nd October 2013
Accepted 8th January 2014
DOI: 10.1039/c3ra46014b
www.rsc.org/advances
This journal is © The Royal Society of CLaccase mediated diclofenac transformation and
cytotoxicity assessment on mouse ﬁbroblast
3T3-L1 preadipocytes
Palanivel Sathishkumar,*a Arumugam Mythili,b Tony Hadibarata,*a
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Diclofenac is recently considered as one of the most devastating environmental pollutants, because of its
biomagniﬁcation in the food chain which leads to potential harmful eﬀects on non-targeted organisms. This
study describes the optimized laccase mediated diclofenac transformation using response surface
methodology (RSM) and cytotoxicity testing on mouse ﬁbroblast 3T3-L1 preadipocytes. Three factors
(laccase, syringaldehyde, reaction time) were used to optimize the diclofenac transformation. The
optimum level of laccase, syringaldehyde and reaction time was found to be 1.91 U mL1, 187 mg and 51
min for diclofenac transformation (20 mg L1). The cytotoxicity assessment on mouse ﬁbroblast 3T3-L1
preadipocytes showed that a maximum of 67.9% cell death occurred at 72 h treatment with diclofenac
(200 mg mL1), while the cells treated with laccase treated diclofenac (LTD) showed less toxicity on the
cells. These ﬁndings can be addressed for the removal of diclofenac toxicity.1 Introduction
Diclofenac is a non-steroidal anti-inammatory drug (NSAID),
used in human and veterinary medicine.1 Global consumption
of diclofenac is about 940 tons per annum.2 It was reported that
the residual existence of diclofenac in eﬄuent from wastewater
treatment plants was found to be between 10 and 2200 ng L1,
which might cause a risk to the ecosystem.3 The diclofenac
metabolism and their adverse eﬀects to living beings have been
studied extensively.1,4–6 In humans and animals, diclofenac is
transferred as hydroxylated derivatives by cytochrome P450
oxidation.7,8 These diclofenac derivatives are excreted with urine
and faeces either in the form of conjugated (glucuronides) or as
nonconjugated dienes and enter into the wastewater stream,
thereby aﬀecting aquatic life.9,10 Stepanova et al.11 observed that
sub-chronic exposure of carp to diclofenac had considerable
toxic eﬀects on the oxidative stress. Moreover, the bio-
magnication of diclofenac in the food chain leads to unpre-
dictable adverse eﬀects on non-target ecological species.12
Therefore, the detoxication of diclofenac is considered to beource Management, Universiti Teknologi
Bahru, Johor, Malaysia. E-mail:
@utm.my; Fax: +60 75531760; Tel: +60
daran College of Science, Coimbatore-14,
of Medicine, University of Malaya, 50603
rsity, Salem-11, Tamil Nadu, India
hemistry 2014essential before it is biomagnied into the food chain. In order
to provide a remedy for this issue, environmental engineers
have been trying to develop various innovative techniques for
the remediation process.
Nowadays, laccase based treatment processes have received
much attention in the bioremediation eld.13–16 Laccase (ben-
zenediol oxygen oxidoreductases; EC 1.10.3.2) is a multi-copper
oxidase enzyme that catalyzes single electron oxidation of four
phenolic molecules with concomitant reduction of oxygen to
water. The active site of the laccase enzyme includes four copper
ions in which type-I (T1, one Cu atom) acts as an electron
acceptor from the substrate, type-II (T2, one Cu atom) copper
forms a tri-nuclear copper-cluster with type-III copper (T3, two
Cu atoms), where the reduction of oxygen takes place.17,18 In
addition, laccase enzymes do not require co-substrates to
facilitate the functions and use the readily available oxygen as
an electron acceptor. The free radicals formed by the action of
laccase bypass the steps involved in the formation of carcino-
genic amines.19 Laccase production from WRF can be easily
enhanced by the addition of inducers and their substrate range
can be extended to non-phenolic compounds in the presence of
small molecular weight redox mediators.20,21
In the laccase–mediator oxidation system, laccase oxidizes
the mediator, which acts as an electron transferring compound
and the mediator transfers the electron from the substrate of
interest. Synthetic redox mediators are commonly used in lac-
case mediated pollutant transformation.22,23However, the use of
these synthetic mediators is limited by their toxic nature and
high cost of exploitation. Interestingly, the free radicalsRSC Adv., 2014, 4, 11689–11697 | 11689
Fig. 1 Molecular structure of (a) diclofenac and (b) syringaldehyde.
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View Article Onlinegenerated from lignin-derived phenols with consequent degra-
dation of the non-phenolic aromatic structures might overcome
such limitations.23 The use of low cost and naturally occurring
eco-friendly lignin-derived phenolic compounds could facilitate
the application of laccase mediated systems for bioremediation
processes.
Recent studies have demonstrated that diclofenac trans-
formation is catalyzed by laccase and reported for diﬀerent rates
of transformation.24–26 These reports clearly indicate that the
rate of transformation mainly depends on several factors such
as diclofenac, laccase, redox mediator concentrations, pH,
temperature, and reaction time. The conventional method used
for the optimization process is time consuming and incom-
plete. Now, the application of central composite design of
response surface methodology (CCD-RSM) in the eﬄuent
treatment process can result in improved degradation rate, as
well as reduced process variability, time, and overall costs. In
addition, the optimum operational conditions and interaction
eﬀects between the factors can be evaluated.27 The previous
study shows that eﬃcient diclofenac transformation is cata-
lyzed by laccase in the presence of the natural mediator syrin-
galdehyde.35 Even though, over certain concentrations of
syringaldehyde caused a slight enzyme denaturation; however,
there is no optimization study on diclofenac transformation
catalyzed by laccase in the presence of syringaldehyde.
Therefore in this study, the most important parameters
involved in the diclofenac transformation such as laccase and
syringaldehyde concentration, also the reaction time was opti-
mized under standard assay conditions using response surface
methodology (RSM). In order to check the eﬃcacy of the model,
a validation experiment was performed with optimized results.
In addition, to understand the cytotoxicity of diclofenac and
laccase treated diclofenac (LTD), the experiment was performed
in mouse broblast 3T3-L1 preadipocytes. This could be
perhaps the rst report for the optimization of laccase mediated
diclofenac transformation and the assessment of its cytotoxicity
in mouse broblast 3T3-L1 preadipocytes.2 Materials and methods
2.1 Chemicals
2,2-Azino-bis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS), diclo-
fenac sodium, Dulbecco's Modied Eagle Medium (DMEM), Fetal
Bovine Serum (FBS), penicillin–streptomycin, syringaldehyde, and
1-(4,5-dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT) were
purchased from Sigma-Aldrich. Mouse broblast 3T3-L1 pre-
adipocytes were obtained from ATCC, USA. All the chemicals and
solvents used in the experiment were of analytical grade. The
molecular structure of diclofenac and syringaldehyde are shown in
Fig. 1.2.2 Laccase source and assay
In this study, Pleurotus oridaNCIM1243 laccase was used as the
biocatalyst and was prepared as described by Palvannan and
Sathishkumar.20 Laccase activity was determined as per the
method of Wolfenden andWilson28 using ABTS as the substrate.11690 | RSC Adv., 2014, 4, 11689–11697The assay mixture consisted of ABTS (1 mM), sodium acetate
buﬀer (100 mM; pH 5.5), and laccase enzyme. Assay mixtures
were placed in a 96-well polypropylene microplate, and incu-
bated at 30 C in an orbital shaker. The increase in absorbance
of the assay mixture was measured at 420 nm (3420 ¼ 36.0 mM1
cm1) in a microplate reader (Biotek, USA) for 2 min intervals,
until the end of the reaction. The activity was expressed as
enzymatic units per volume and one unit (1 U) of activity was
dened as the amount of laccase that oxidized 1 mmol of ABTS
per minute.2.3 Response surface methodology
The diclofenac transformation was optimized using RSM. Three
independent factors of laccase (A), syringaldehyde (B), and
reaction time (C) were used at ve levels (1.68, 1, 0, +1,
+1.68), a second order central composite experimental design
was followed. The range and levels of these parameters are
shown in Table 1. The experimental range for the independent
factors in the coded (xi) and actual (Xi) levels are given in Table
2. A set of 20 runs were designed in order to optimize the
independent factors and six replicates at the center point were
performed to provide information on the variation of responses
about the average and residual variance. For statistical calcu-
lations, the factor Xi was coded as xi according to eqn (1):
xi ¼ ðXi  X0Þ
dX
(1)
where xi is the coded value, Xi is the actual value, X0 is the center
point value and dX is the step change between the factor levels.
The diclofenac transformation (%) was considered as the
response (dependent factors). In order to show the relationship
between dependent and independent factors, the response was
tted with a second order polynomial model. The system
behavior of the model was explained using eqn (2):
Y^ ¼ b0 þ
Xk
i¼1
biXi þ
Xk
i¼1
biiXi
2 þ
X
i
X
j
bijXiXj (2)
where Yˆ is the predicted response (percentage of diclofenac
transformation), b0 is a constant, bi is the linear coeﬃcient
term, bii is the quadratic coeﬃcient term, and bij is the inter-
action coeﬃcient.
2.3.1 Soware and data analysis. The Design-Expert 8.0.7.1
(Stat-Ease, Inc., Minneapolis, USA) was used to analyze the RSM
response in order to determine the analysis of variance
(ANOVA), three dimensional (3D) response surface plot, inter-
active eﬀects of the factors, and their corresponding optimum
levels.This journal is © The Royal Society of Chemistry 2014
Table 1 Factors investigated in the experimental design
Factors Code
Range of variables and level
Step change value
(DZi)2 1 0 +1 +2
Laccase (U mL1) A 0.66 1 1.5 2 2.34 0.5
Syringaldehyde (mM) B 23.87 75 150 225 276.13 75
Reaction time (min) C 6.36 20 40 60 73.64 20
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View Article Online2.4 Diclofenac transformation
Diclofenac sodium (1000 mg L1) stock solution was prepared
in 50% methanol (v/v), and further appropriate dilutions were
made for the transformation experiments. The transformation
experiments were carried out in a test tube containing 10 mL of
reaction mixture with laccase and syringaldehyde (as per CCD
design mentioned in Table 2) at a xed concentration of
diclofenac (20 mg L1) in sodium acetate buﬀer (100 mM; pH
4.5) at 30 C, 50 rpm under dark conditions. As per CCD design,
the reaction time of each run was maintained and the reaction
was stopped by acidication with H2SO4. All the experiments
were performed in duplicate and the reported values are the
average of at least three experiments.
2.4.1 Diclofenac transformation analysis in HPLC. Diclo-
fenac transformation was assessed using HPLC. An HP 1200
(Agilent, USA) liquid chromatography equipped with 2.1 mm 
150 mm Eclipse C18 capillary column, particle size 3.5 mm
(Agilent, USA) was used to determine the diclofenac trans-
formation. The percentage of diclofenac transformation is
determined by the following eqn (3):Table 2 Full factorial CCD design matrixa
Std
Coded variables
A – laccase
(U mL1)
B – syringaldehyde
(mM)
C – reactio
(h)
1 1[2.5] 1[200] 1[60]
2 +1[7.5] 1[200] 1[60]
3 1[2.5] +1[400] 1[60]
4 +1[7.5] +1[400] 1[60]
5 1[2.5] 1[200] +1[120]
6 +1[7.5] 1[200] +1[120]
7 1[2.5] +1[400] +1[120]
8 +1[7.5] +1[400] +1[120]
9 1.68[0.5] 0[300] 0[90]
10 +1.68[10] 0[300] 0[90]
11 0[5] 1.68[100] 0[90]
12 0[5] +1.68[500] 0[90]
13 0[5] 0[300] 1.68[30]
14 0[5] 0[300] +1.68[150]
15 0[5] 0[300] 0[90]
16 0[5] 0[300] 0[90]
17 0[5] 0[300] 0[90]
18 0[5] 0[300] 0[90]
19 0[5] 0[300] 0[90]
20 0[5] 0[300] 0[90]
a Data are given as mean  S.D., n ¼ 3.
This journal is © The Royal Society of Chemistry 2014D ¼

Ai  Af

Ai
 100 (3)
where D is the percentage of diclofenac transformation, Ai is the
total area under the plot, and Af is the nal area under the plot.2.5 Cytotoxicity study on cell culture and MTT assay
Themouse broblast 3T3-L1 preadipocytes were cultured in a 75
cm2 ask with RPMI-1640 supplemented with 10% FBS, 10 units
of penicillin and 10 mg mL1 streptomycin was maintained in an
incubator at 5% CO2 and 37 C. The cells were harvested and
seeded in a 96-well cell culture plate at a density of 5  104 cells
per well. A concentration of 200 mg mL1 for diclofenac and LTD
were added to the cells and further incubated for 24, 48, and 72
h. Aer treatment, 10 mL MTT (5 mg mL1) was added to each
well and incubated for 4 h. The supernatant was discarded and
100 mL of isopropanol was added to each of the wells and the
plate was read using a plate reader at 598 nm. The cell viability
was calculated by the following eqn (4):Response – diclofenac degradation (%)
n time Actual data
(Yj)
Predicted
data (Yˆ j)
Residual value
(Yj  Yˆ j)
39  3.2 32 7
37  2.6 38 1
32  1.8 30 2
66  4.0 64 2
66  2.7 67 1
83  4.1 84 1
61  2.5 59 2
100  0 106 6
31  3.7 36 5
84  4.1 79 5
56  3.3 58 2
75  3.8 73 2
24  3.4 30 6
97  2.2 92 5
80  2.1 79 1
80  2.1 79 1
80  2.1 79 1
80  2.1 79 1
80  2.1 79 1
80  2.1 79 1
RSC Adv., 2014, 4, 11689–11697 | 11691
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Ac
 100 (4)
where V is cell viability (%), At is absorption of the test, and Ac is
absorption of the control and the results are provided as means
 SD values. The level of signicance between samples was
calculated using SPSS statistics 20 soware.3 Results and discussion
3.1 Diclofenac transformation optimization using RSM
The physico-chemical properties such as pH, temperature,
substrate, enzyme and redox-mediator concentrations, and
reaction time plays a vital role in every biochemical trans-
formation. Generally, the redox potential and optimum pH are
dependent not only on the laccase properties but also on the
properties of the target substrate.26 Therefore, in the rst series
of experiments, the optimum pH for diclofenac transformation
and stability nature of laccase was evaluated in order to eluci-
date the most favorable reaction conditions for subsequent
removal experiments. Fig. 2a shows the optimum pH for the
laccase catalyzed diclofenac transformation. The maximum
percentage of diclofenac transformation was achieved from 4 to
5.5 with an optimum at pH 4.5. Similarly, Lloret et al.24 obtained
the maximum diclofenac degradation at pH 4.5 with commer-
cial laccase from Myceliophthora thermophila. The stability
results showed that the half-life of initial activity retained up to
5 h at pH 4.5 (Fig. 2b). In the case of high acidic and near neutral
pH conditions the diclofenac transformation decreased. This
drop of reactivity at alkaline pH is probably due to the combi-
nation of hydroxide ion inhibition and it's binding with the
T2/T3 site of laccase andmoreover the decrease in the reduction
potential of oxygen would certainly lead to a reduction of reac-
tion rates.29 The decrement of reactivity at high acid pH is
mainly due to the presence of ionizable side-chains in the
tertiary structure of the enzyme.24 Nevertheless, the enzyme can
be denatured at extreme pH because of the conformationalFig. 2 Eﬀect of pH on (a) diclofenac transformation and (b) laccase stabili
U L1) and syringaldehyde (250 mM) at 30 C, 50 rpm.
11692 | RSC Adv., 2014, 4, 11689–11697changes.30 Consequently, the diclofenac transformation exper-
iment was carried out at 4.5 pH.
Previously, it was found that syringaldehyde had an imme-
diate eﬀect on laccase mediated diclofenac transformation.31 In
the laccase–syringaldehyde oxidation system; laccase oxidizes
the syringaldehyde, which acts as an electron transferring
compound and the syringaldehyde transfers the electron from
the substrate of interest (diclofenac). However, syringaldehyde
might give a negative eﬀect over certain concentrations by
inhibiting the laccase activity.24 Therefore, optimization of lac-
case mediated diclofenac transformation is considered impor-
tant for scaling-up. In this study, laccase and syringaldehyde
concentrations and their reaction time were selected as factors
with xed level of diclofenac concentration for diclofenac
transformation optimization. Table 2 shows the design matrix
together with both factor level and obtained experimental
response value. Diclofenac transformation percentage was
found in the range between 24 and 100%, respectively. The RSM
experimental response was analyzed with Design-Expert so-
ware so as to obtain an empirical model for the best response.
The experimental and predicted diclofenac transformation (%)
is shown in Table 2. Actual values correspond to the measured
response data for a particular run and the predicted values were
evaluated from the model. A quadratic model was used to
explain the mathematical relationship between the indepen-
dent factors and dependent response.
The signicance and adequacy of the models were justied
with variance (ANOVA) and the results were analyzed using
ANOVA as shown in Table 3. These results indicate that the
model is highly signicant, as it is evident from the Fisher's F-
test with a very low probability value of [(Pmodel > F) ¼ 0.0001].
The predicted R2 value (0.856) was in reasonable agreement
with the adjusted R2 value (0.965). Themodel consistency t can
be expressed by the coeﬃcient of regression R2 and was found to
be 0.9817; this data representing 98.17 percentage variability in
the response could be explained by this model. This implies
that R2 values of the model had advocated a high correlation
between the experimental and predicated response, indicatingty. The reactionwas performedwith diclofenac (20mg L1), laccase (2.5
This journal is © The Royal Society of Chemistry 2014
Table 3 ANOVA results for the response surface quadratic modela
Source Sum of squares Degrees of freedom Mean square F value Prob. > F
Model 9641 9 1071 60 <0.0001 Signicant
A 2298 1 2297 128 <0.0001 Signicant
B 319 1 319 18 0.0018 Signicant
C 4903 1 4903 272 <0.0001 Signicant
AB 421 1 421 23 0.0007 Signicant
AC 72 1 72 4 0.0734
BC 13 1 13 1 0.4241
A2 889 1 889 49 <0.0001 Signicant
B2 364 1 364 20 0.0011 Signicant
C2 665 1 665 37 0.0001 Signicant
Residual 180 10 18
Lack of t 180 5 36
Pure error 0 5 0
Cor total 9821 19
a Std. dev. – 4.242; mean – 66.55; C.V.% – 6.374; PRESS – 1405; R2 – 0.9817; adj R2 – 0.965; pred R2 – 0.856; adeq. precision – 25.71.
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View Article Onlinethat the predicted values for diclofenac transformation percent
would be closer to its actual value. From the P-values, it was
found that linear terms of laccase (A), syringaldehyde (B),
reaction time (C), quadratic terms of laccase (A2), syringalde-
hyde (B2), reaction time (C2), interaction between laccase and
syringaldehyde (AB) were signicant model terms for the
diclofenac transformation. In addition, a relatively low coeﬃ-
cient variation value (CV ¼ 6.374) proved higher consistency of
the experiments for diclofenac transformation.32
The overall second-order polynomial equation represents the
mathematical model relating to the percent of diclofenac
transformation with independent factors as seen from eqn (5):
Y ¼ 79.98 + 12.97A + 4.83B + 18.95C  7.85A  5.03B
 6.79C2 + 7.25AB + 3.00AC  1.25BC (5)
where Y is diclofenac transformation (%), A is laccase concen-
tration (U mL1), B is syringaldehyde concentration (mM), and C
is reaction time (min). The interaction eﬀects of selected factors
on diclofenac transformation are shown in Fig. 3(a–c). The three-
dimensional (3D) plot was constructed by plotting the factors of
the central point which aﬀects the percent of diclofenac trans-
formation (laccase (1.5 U L1), syringaldehyde (150 mM) and
reaction time (40 min). The inuence of laccase and syringalde-
hyde on the response at a xed reaction time 1.5 U L1 is illus-
trated in Fig. 3a. Moreover, the increase in both laccase and
syringaldehyde concentration yielded an increase in the response
surface. The response value reached its maximum level at 1.76 U
L1 for laccase and 1.82 mM for syringaldehyde, respectively. This
result also showed that increasing laccase and syringaldehyde
concentration does not increase the diclofenac transformation
beyond the above mentioned level. In general, the reaction rate
increases with increase in either substrate or enzyme concen-
tration up to a certain level and the reaction rate reaches a
plateau and maintains a constant level aer saturation.33
The eﬀect of laccase and reaction time on the response at
xed syringaldehyde concentration of 150 mM is shown in
Fig. 3b. The 3D plot revealed that the percentage of diclofenacThis journal is © The Royal Society of Chemistry 2014transformation has increased with the increase in laccase
concentration and decreased in reaction time. The maximum
level of transformation was obtained at 1.65 U L1 of laccase
concentration with 45 min of reaction time. This result clearly
indicated that the increasing level of laccase enzyme concen-
tration could transfer diclofenac within a shorter reaction time.
The eﬀect of syringaldehyde and reaction time at a xed laccase
concentration of 40 min is shown in Fig. 3c. This result
conrms that the percent of diclofenac transformation
decreased with increase in syringaldehyde and increased with
increase in reaction time. The maximum diclofenac trans-
formation obtained for the concentration of syringaldehyde and
reaction time was found to be 160 mM and 42 min. It can be
observed that the percent of transformation decreased with
increase in concentration of syringaldehyde even during the
extended reaction time. This result shows that syringaldehyde
might be inhibiting the laccase activity over a certain amount of
concentration. Lloret et al.24 reported that the presence of
syringaldehyde at concentrations higher than the optimum
level might cause remarkable enzyme inactivation. Conse-
quently, the current study also conrms the signicance of
syringaldehyde concentration optimization for diclofenac
transformation which is catalysed by laccase and also coincides
with the ndings of Lloret et al.24 The predicted maximum
diclofenac transformation derived from RSM regression was
obtained with laccase, syringaldehyde, and reaction time of
1.91 U mL1, 187 m, and 51 min, respectively.
To check the model eﬃciency, laccase mediated diclofenac
transformation was performed under an optimized level of
factors (laccase, syringaldehyde and reaction time) obtained
from this study. The results of Fig. 4 show that complete
transformation of diclofenac is possible. This result also
suggests that the actual percent of transformation in the opti-
mized conditions are close to the predicted value and the model
was once again proven to be adequate. Marco-Urrea34 observed
95% diclofenac transformation (40 mg L1) with laccase alone
(2000 U L1) in pH 4.5 at 4½ h. Lloret et al.24 reported complete
transformation of diclofenac (5 mg L1) with 2000 U L1 laccaseRSC Adv., 2014, 4, 11689–11697 | 11693
Fig. 3 3D plot of the interactions between factors for laccase mediated diclofenac degradation. Interaction eﬀect between (a) laccase and
syringaldehyde, (b) laccase and reaction time, (c) syringaldehyde and reaction time.
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View Article Onlineand 1 mM syringaldehyde with pH 4 at 1 h. The complete
transformation of diclofenac (10 mg L1) was obtained with 2000
U L1 laccase in the presence of 1-hydroxybenzotriazole or ABTS
with pH 4.5 at 3 h by Tran et al.35 The optimization results of this
study clearly show that the maximum percentage of diclofenac
transformation was achieved with the minimum concentration
of laccase and syringaldehyde at a shorter reaction time.
The chromatograms of diclofenac and LTD samples are
illustrated in Fig. 4a and b, which are obtained from HPLC
analysis. The diclofenac peak was well-resolved with a retention
time of 5.831 min (Fig. 4a). In the case of LTD, a peak which
appeared at 5.831 min completely disappeared and new diclo-
fenac transformed peaks appeared at the retention times of
3.379, 2.554, 2.124, 1.930, 1.814, 1.656, 1.572, and 1.183, as
shown in Fig. 4b. On-going eﬀorts are currently focused on the
documentation of transformation by-products aiming to eluci-
date the complete laccase mediated transformation of diclofe-
nac. Even though, diclofenac transformation mechanisms and
their metabolic products were discussed with available literature
data. Recently, Lloret et al.36 detected product I decarboxylated
compound, [2-[(2,6-dichlorophenyl)amino]phenyl]methanol as a
laccase mediated diclofenac transformation by-product. In
addition, they hypothetically proposed 2,6-dichloro-N-o-tol-
ylbenzenamine as product II. Marco-Urrea et al.34 reported that11694 | RSC Adv., 2014, 4, 11689–11697the laccase-catalyzed transformation of diclofenac leads to the
formation of 4-(2,6-dichlorophenylamino)-1,3-benzenedimetha-
nol, and two hydroxylated metabolites, namely 40-hydroxy-
diclofenac and 5-hydroxydiclofenac were elucidated as trans-
formation intermediates in fungal culture (Trametes versicolor)
spiked with diclofenac. Soufan et al.37 investigated the reactivity
and fate of diclofenac during water chlorination and identied
three major derivatives like decarboxy-DCF (Product I), chloro-
decarboxy-DCF (Product II), and chloro-DCF (Product III).
Mart´ınez et al.38 observed eight metabolites from diclofenac
photo-degradation, mainly corresponding to the photo-
cyclisation (2-(8-chloro-9H-carbazol-1-yl)acetic acid, 1-chloro-8-
methyl-9H-carbazole), decarboxylation (2,6-dichloro-N-o-tolyl-
benzenamine) and dehalogenation. Huguet et al.39 studied
diclofenac elimination by means of fast chemical oxidation on
natural manganese oxide in a column reactor and observed that
diclofenac transformation by-products such as 5-hydroxy-
diclofenac and 5-iminoquinone with the mechanism of decar-
boxylation, iminoquinone formation, and dimerization. Michael
et al.40 reported that diclofenac degradation by (sono)photo-
catalysis, mainly proceeds with the oxidation and hydroxylation
reactions occurring between chloroaniline and phenylacetic
acid. However, still the detailed study on laccase mediated
diclofenac transformation pathway is not elucidated. Therefore,This journal is © The Royal Society of Chemistry 2014
Fig. 4 HPLC chromatogram of (a) diclofenac and (b) laccase treated diclofenac (LTD).
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View Article Onlinefurther research is needed for understanding the complete
mechanism and pathway elucidation for the laccase mediated
diclofenac transformation processes.3.2 Cytotoxicity of diclofenac and LTD on mouse 3T3-L1
preadipocytes
Diclofenac is found to be toxic for liver and kidney cells of both
humans and animals. It is directly involved in causing renal
failure, gastro intestinal toxicity and idiosyncratic hepatic
injury.41,42 The residues of veterinary diclofenac are the major
causes of death in the vultures of India and Nepal.43 To assess
and compare the toxicity of LTD, mouse 3T3-L1 preadipocytes
were cultured and treated with both diclofenac and LTD. The
cell viability was used to assess the toxicity induced from both
the samples. Eﬀects of diclofenac and LTD were tested on
mouse 3T3-L1 preadipocytes. As the drugs were dissolved in
water, no vehicle control was used. The cells treated with 200 mg
mL1 diclofenac induced cell death. A decrease in cell viability
of 61.6, 64.7 and 67.9% was observed at 24, 48 and 72 h,
respectively (Fig. 5). Recent reports show that, among fourThis journal is © The Royal Society of Chemistry 2014diﬀerent pharmaceutical compounds (atenolol, carbamaze-
pine, diclofenac and gembrozil), diclofenac has the elevated
cytotoxic eﬀect on zebra mussel cell line, even at mg level.44 The
ndings of the current study also conrm the cytotoxicity of the
diclofenac drug towards the mouse 3T3-L1 preadipocytes. A
decrease of 14.6, 16.9 and 23.3% cell viability was observed
when the cells were treated with LTD for 24, 48 and 72 h. This
result suggests a low level of apoptotic cell death was induced by
LTD when compared to diclofenac induced cell death in mouse
broblast cells. This is considered to be the rst report on the
toxicity of diclofenac drug and LTD on mouse broblast cells.
Finally, the result of cytotoxicity studies shows that diclofe-
nac induced cell death; whereas, laccase treated diclofenac did
not induce considerable cell death. This shows that contami-
nation of diclofenac in the water system may induce health
disorders among the consumers. Generally, diﬀerent kinds of
treatment methods (biological, chemical, and physical) are
involved in the water treatment plants for water purication.
This proposed laccase mediated treatment system will reduce
the toxicity of diclofenac and further treatment systems like
absorbance process involved in the water treatment plant willRSC Adv., 2014, 4, 11689–11697 | 11695
Fig. 5 Eﬀect of diclofenac and LTD on mouse 3T3-L1 preadipocytes.
Treatment of 200 mg mL1 diclofenac induced cell death in mouse
cells in a time-dependent manner and the data were signiﬁcant at p <
0.05. Whereas the cells treated with LTD showed a slight decrease in
cell viability, which shows that LTD is less toxic to the cells. Values are
represented as mean SD, * denotes p < 0.05 signiﬁcant from control.
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View Article Onlineremove the degraded compounds. Therefore, in this way
detoxication of diclofenac may help in water purication.4 Conclusions
In this study, the cytotoxic eﬀect of diclofenac on mouse 3T3-L1
preadipocytes was conrmed. The cytotoxicity of diclofenac was
completely removed aer laccase treatment in the presence of
syringaldehyde under optimized conditions. This environ-
mental friendly strategy can provide a solution and insight for
removing diclofenac toxicity.Acknowledgements
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